X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1456) 1456
Publication (191) 191
Book Chapter (31) 31
Book Review (29) 29
Government Document (12) 12
Conference Proceeding (8) 8
Dissertation (7) 7
Book / eBook (3) 3
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (761) 761
index medicus (745) 745
anti-angiogenic therapy (690) 690
oncology (550) 550
angiogenesis (522) 522
animals (487) 487
cancer (481) 481
endothelial growth-factor (357) 357
bevacizumab (283) 283
female (275) 275
angiogenesis inhibitors - therapeutic use (272) 272
vascular endothelial growth factor (248) 248
mice (245) 245
anti-angiogenic (233) 233
male (228) 228
tumors (218) 218
chemotherapy (214) 214
angiogenesis inhibitors - pharmacology (210) 210
neovascularization, pathologic - drug therapy (199) 199
pharmacology & pharmacy (190) 190
metastasis (176) 176
vegf (171) 171
neoplasms - drug therapy (156) 156
antiangiogenic therapy (151) 151
care and treatment (149) 149
tumor angiogenesis (148) 148
antineoplastic agents (144) 144
antimitotic agents (140) 140
analysis (139) 139
cell line, tumor (137) 137
therapy (129) 129
expression (124) 124
middle aged (119) 119
growth (118) 118
in-vivo (116) 116
treatment outcome (113) 113
article (112) 112
antineoplastic agents - therapeutic use (111) 111
research (109) 109
health aspects (108) 108
neoplasms - blood supply (108) 108
aged (103) 103
medicine & public health (99) 99
angiogenesis inhibitors (96) 96
cell biology (96) 96
anti-angiogenic agents (95) 95
biochemistry & molecular biology (95) 95
cells (95) 95
adult (94) 94
antineoplastic agents - pharmacology (94) 94
inhibition (91) 91
vascular endothelial growth factor a - metabolism (91) 91
tumor-growth (89) 89
vascular endothelial growth factor a - antagonists & inhibitors (89) 89
cancer therapies (88) 88
neovascularization (88) 88
neovascularization, pathologic - pathology (87) 87
glioblastoma (84) 84
hypoxia (83) 83
phase-ii trial (83) 83
breast-cancer (82) 82
cell proliferation - drug effects (82) 82
renal-cell carcinoma (82) 82
review (81) 81
apoptosis (80) 80
endothelium (77) 77
medicine, research & experimental (77) 77
angiogenesis inhibitors - administration & dosage (75) 75
drug therapy (75) 75
xenograft model antitumor assays (74) 74
chemistry, medicinal (73) 73
endothelial cells (73) 73
tyrosine kinase inhibitor (73) 73
rats (70) 70
antineoplastic combined chemotherapy protocols - therapeutic use (69) 69
in-vitro (69) 69
survival (69) 69
immunotherapy (68) 68
mice, nude (66) 66
cancer research (65) 65
neoplasms - pathology (65) 65
sunitinib (65) 65
brain neoplasms - drug therapy (64) 64
anti-angiogenic activity (62) 62
colorectal cancer (62) 62
endothelial-cells (62) 62
metastatic colorectal-cancer (62) 62
hematology, oncology and palliative medicine (61) 61
neovascularization, pathologic - metabolism (60) 60
dose-response relationship, drug (59) 59
proteins (58) 58
solid tumors (58) 58
breast cancer (57) 57
clinical trials (57) 57
immunohistochemistry (57) 57
anti-angiogenic agent (56) 56
neovascularization, pathologic (56) 56
phase-iii trial (56) 56
prognosis (56) 56
tumor (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1420) 1420
French (52) 52
German (13) 13
Japanese (5) 5
Spanish (5) 5
Korean (3) 3
Polish (2) 2
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 518 - 529
Summary Angiogenesis, the formation of new blood vessels from pre-existing vessels, has been validated as a target in several tumour types through randomised... 
Internal Medicine | PHASE-III TRIAL | ADVANCED HEPATOCELLULAR-CARCINOMA | BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | PANCREATIC NEUROENDOCRINE TUMORS | TYROSINE KINASE INHIBITOR | RECURRENT OVARIAN-CANCER | ANTI-ANGIOGENIC THERAPY | RESISTANT PROSTATE-CANCER | METASTATIC COLORECTAL-CANCER | RENAL-CELL CARCINOMA | Neoplasms - metabolism | Niacinamide - analogs & derivatives | Humans | Drug Resistance, Neoplasm | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Angiogenesis Inhibitors - therapeutic use | Biomarkers, Tumor - metabolism | Female | Neovascularization, Pathologic - prevention & control | Molecular Targeted Therapy - methods | Receptor, TIE-2 - antagonists & inhibitors | Angiogenesis Inhibitors - pharmacology | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Neoplasms - blood supply | Piperazines - therapeutic use | Angiopoietin-1 - antagonists & inhibitors | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Neoplasms - drug therapy | Biomarkers, Tumor - blood | Disease-Free Survival | Phthalazines - therapeutic use | Signal Transduction - drug effects | Neovascularization, Pathologic - drug therapy | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinolines - therapeutic use | Antimitotic agents | Pancreatic cancer | Melanoma | Neovascularization | Antineoplastic agents | Vascular endothelial growth factor | Prostate cancer | Cervical cancer | Drugs | Angiogenesis | Chemotherapy | Clinical trials | Oncology | Metastasis | Cancer therapies | Tumors | Cancer
Journal Article
Seminars in Cancer Biology, ISSN 1044-579X, 2015, Volume 35, Issue Suppl, pp. S224 - S243
Journal Article
Cytokine and Growth Factor Reviews, ISSN 1359-6101, 2014, Volume 25, Issue 4, pp. 473 - 482
Journal Article
Journal Article